{"output": [["Seattle Genetics Inc", "COMP", "Announce", "FDA grants priority review status", "EVENT"], ["Seattle Genetics Inc", "COMP", "Produce", "ADCETRIS\u00ae", "PRODUCT"], ["ADCETRIS\u00ae", "PRODUCT", "Control", "Hodgkin Lymphoma treatment", "PRODUCT"], ["FDA grants priority review status", "EVENT", "Relate_To", "Supplemental Biologics License Application", "EVENT"], ["Supplemental Biologics License Application", "EVENT", "Operate_In", "FDA", "ORG/GOV"], ["ADCETRIS\u00ae", "PRODUCT", "Impact", "Frontline Advanced Hodgkin Lymphoma", "CONCEPT"], ["Prescription Drug User Fee Act", "EVENT", "Has", "May 1, 2018", "DATE"]], "published": "2018-01-02T15:10:00.000+02:00"}